INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 422m ago
House PTR21m ago
SEC 13F21m ago
Robinhood Chain21m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 90S90 trades$362K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,797 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
297.0K sh
Feb 13, 2026Feb 17, 2026
Page 1308 of 1795
← PrevNext →
traded Feb 13, 2026
+4d
SEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
30 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

8
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
20.0K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Tax withholding
F$100K
1,290 sh
Feb 14, 2026Feb 17, 2026
traded Feb 14, 2026
+3dSEC Form 4

Evidence

8
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
18.8K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
112.5K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
120.0K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

5
FM
Flatley Edith MorganEVP - Global CMO
MCDMCDONALDS CORP
Tax withholding · 10b5-1 plan
F$261K
798 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

5
FM
Flatley Edith MorganEVP - Global CMO
MCDMCDONALDS CORP
Option exercise · 10b5-1 plan
M—
4,692 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

5
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise
M—
250 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

5
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
50 sh
Feb 17, 2026Feb 17, 2026
traded Feb 17, 2026
+0dSEC Form 4

Evidence

5
MM
Macchi MauroChief Executive Officer-EMEA
ACNAccenture plc
Grant or award
A—
27 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

5
MM
Macchi MauroChief Executive Officer-EMEA
ACNAccenture plc
Tax withholding
F$3,362
15 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

5
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Grant or award
A—
41 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

3
FM
Flatley Edith MorganEVP - Global CMO
MCDMCDONALDS CORP
Option exercise · 10b5-1 plan
M—
1,859 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

2
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Grant or award
A—
39 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

0
BL
Buttermore Robert L.SVP,Chief Supply Chain Officer
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M—
568 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

0
FM
Flatley Edith MorganEVP - Global CMO
MCDMCDONALDS CORP
Option exercise · 10b5-1 plan
M—
1,859 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

0
FM
Flatley Edith MorganEVP - Global CMO
MCDMCDONALDS CORP
Option exercise · 10b5-1 plan
M—
135 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

0
FM
Flatley Edith MorganEVP - Global CMO
MCDMCDONALDS CORP
Option exercise · 10b5-1 plan
M—
135 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

0
FM
Flatley Edith MorganEVP - Global CMO
MCDMCDONALDS CORP
Grant or award · 10b5-1 plan
A—
26.1K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

0
BL
Buttermore Robert L.SVP,Chief Supply Chain Officer
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M—
568 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

48
CS
Cohen StephenSenior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$2.34M
2,179 sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC Form 4

Evidence

48
SS
Schwar StephenVice Chair of CCM
CSLCARLISLE COMPANIES INC
Open-market sale
SELL$1.90M
4,549 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

44
GM
Goetter Gina MEVP & CFO
HASHASBRO, INC.
Open-market sale
SELL$1.29M
12.4K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

42
DS
de Montlivault StephanePresident, Otis Asia Pacific
OTISOtis Worldwide Corp
Open-market sale
SELL$4.42M
47.9K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

41
BM
Bunge Jason MChief Marketing Officer
HASHASBRO, INC.
Open-market sale
SELL$252K
2,380 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

41
SS
Schwar StephenVice Chair of CCM
CSLCARLISLE COMPANIES INC
Open-market sale
SELL$626K
1,500 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

40
VR
Vicks Raymond Jr.Director
TENBTenable Holdings, Inc.
Open-market purchase
BUY$100K
4,500 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

40
GJ
Gowans JasonEVP and CDTO
LEVILEVI STRAUSS & CO
Open-market sale
SELL$873K
40.0K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

39
TF
Tematio Jean FelixVP, CAO & Corporate Controller
UGIUGI CORP /PA/
Open-market sale
SELL$489K
12.8K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC Form 4

Evidence

38
HN
Holtz NaftaliChief Financial Officer
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$4.18M
12.7K sh
Feb 13, 2026Feb 13, 2026
traded Feb 13, 2026
+0dSEC Form 4

Evidence

36
RE
Renjel Louis E.EVP&CEO DEF&MW&ChiefCorpAffOff
DUKDuke Energy CORP
Open-market sale
SELL$868K
6,800 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

36
MF
Moghal Ahmed FarhanEVP, Chief Financial Officer
BKRBaker Hughes Co
Open-market sale · 10b5-1 plan
SELL$1.11M
18.1K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

35
DE
Dougherty Justin EEVP, Global Operations
CRUSCIRRUS LOGIC, INC.
Open-market sale
SELL$429K
3,000 sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC Form 4

Evidence

34
BC
Bellows CliveCo-President Asset Servicing
NTRSNORTHERN TRUST CORP
Open-market sale
SELL$167K
1,148 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

34
HN
Holtz NaftaliChief Financial Officer
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.00M
9,172 sh
Feb 13, 2026Feb 13, 2026
traded Feb 13, 2026
+0dSEC Form 4

Evidence

34
HN
Holtz NaftaliChief Financial Officer
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.61M
11.0K sh
Feb 13, 2026Feb 13, 2026
traded Feb 13, 2026
+0dSEC Form 4

Evidence

34
GG
Gibson GuyCo-President Asset Servicing
NTRSNORTHERN TRUST CORP
Open-market sale
SELL$154K
1,043 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

34
VE
Virnig Michael EdwardPresident, Specialty Vehicles
TEXTEREX CORP
Open-market sale
SELL$1.10M
16.3K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence